Pyrimidine derivatives as selective inhibitors of cox-2

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C544S332000

Reexamination Certificate

active

07074802

ABSTRACT:
The invention thus provides the compounds of formula (I)and pharmaceutically acceptable salts thereof, in which:R1and R2are independently selected from the group consisting of H, C1-6alkyl, C2-6alkenyl, C3-6alkynyl, C3-10cycloalkylC0-6alkyl and C4-12bridged cycloalkyl;R3is selected from the group consisting of C1-6alkyl, NH2and R5CONH;R4is selected from the group consisting of CH2F, CHF2, CF3CH2, CF3CHF and CF3CF2; andR5is selected from the group consisting of H, C1-6alkyl, C1-6alkoxy, C1-6alkylOC1-6alkyl, phenyl, HO2CC1-6alkyl, C1-6alkylOCOC1-6alkyl, C1-6alkylOCO, H2NC1-6alkyl, C1-6alkylOCONHC1-6alkyl and C1-6alkylCONHC1-6alkyl.Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of the pain, fever, inflammation of a variety of conditions and diseases.

REFERENCES:
patent: 3149109 (1964-09-01), Neustaedter et al.
patent: 3592895 (1971-07-01), Hepworth et al.
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5760068 (1998-06-01), Talley et al.
patent: 5972986 (1999-10-01), Seibert et al.
patent: 6020343 (2000-02-01), Belley et al.
patent: 6153619 (2000-11-01), Wood et al.
patent: 6306866 (2001-10-01), Wood et al.
patent: 6313072 (2001-11-01), Scheiblich et al.
patent: 6780869 (2004-08-01), Green et al.
patent: 6780870 (2004-08-01), Naylor et al.
patent: 2003/0013717 (2003-01-01), Mangel et al.
patent: 19909541 (1999-03-01), None
patent: 9241161 (1997-09-01), None
patent: WO 96/07641 (1996-03-01), None
patent: WO 96/24585 (1996-08-01), None
patent: WO 96/41625 (1996-12-01), None
patent: WO 96/41645 (1996-12-01), None
patent: WO/98/03484 (1998-01-01), None
patent: WO 98/16227 (1998-04-01), None
patent: WO/98/24782 (1998-06-01), None
patent: WO 99/01439 (1999-01-01), None
patent: WO/01/38311 (2001-05-01), None
patent: WO/01/58881 (2001-08-01), None
patent: WO/02/18374 (2002-03-01), None
patent: WO/02/096427 (2002-12-01), None
patent: WO/02/096885 (2002-12-01), None
patent: WO/02/096886 (2002-12-01), None
Simone, J.V., “Oncology: Introduction” Cecil Texbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Layzer, R.B., “Degenerative Diseases of the Nervous System” Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.
Damasio, A.R. “Alzheimer's Disease and Related Dementias” Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1992-1996, 1996.
Freston, JW. “Rationalizing Cyclooxygenase (COX) Inhibition for Maximal Efficacy and Minimal Adverse Events & Discussion.” PubMed Abstract, Am J Med 107(6A):78S-88S, Discussion 89S), Dec. 1999.
Naesdal, J. et al. “Gastro-Duodenal Protection in an Era of Cyclo-Oxygenase-2-Selective Nonsteroidal Anti-inflammatory Drugs.” PubMed Abstract, Eur J Gastroenterol Hepatol, 13(12):1401-1406, Dec. 2001.
Douglas, R.G., Jr. Introduction to Viral Diseases: Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1739-1747, 1996.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Pyrimidine derivatives as selective inhibitors of cox-2 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pyrimidine derivatives as selective inhibitors of cox-2, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyrimidine derivatives as selective inhibitors of cox-2 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3551641

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.